HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend0.00%

6.49%
1 Year Return
Equity
Arbitrage
6M
1Y
3Y
All

Fund Details

HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend

RiskModerately Low
Min SIP AmountNot Supported
Expense Ratio0.02%
NAV10.00 (05 May 2020)
Fund Started27 Mar 2017
Fund Size133 Cr

Returns

1Y
3Y*
5Y*
Since inception*
HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend
6.5%
6.5%
NA
6.6%
Category Average
4.0%
5.3%
5.8%
-
Rank within category
1
1
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    For how many years?
    1 Year
    3 Years
    Estimated Value
    as per Historical Returns
    0
    with 6.5% annual returns

    Comparison

    Data not available
    Pros
    Found nothing so far.
    Cons
    Found nothing so far.

    Top Holdings

    NameSectorInstrument% Assets
    IDFC First Bank Ltd.FinancialFixed Deposits15.7%
    Housing Development Finance Corpn. Ltd.FinancialEquity8.3%
    Reliance Industries Ltd.EnergyEquity7.0%
    JM Financial Asset Reconstruction Company LtdFinancialDebenture6.9%
    Larsen & Toubro Ltd.ConstructionEquity5.3%
    ITC Ltd.FMCGEquity5.1%
    National Bank For Agriculture & Rural DevelopmentFinancialBonds3.8%
    State Bank of IndiaFinancialEquity2.1%
    Mahindra & Mahindra Ltd.AutomobileEquity2.0%
    Tech Mahindra Ltd.TechnologyEquity1.9%
    See All

    Fund Managers

    addKrishan Kumar Daga
    Education
    Mr. Daga is a B.Com (H).
    Experience
    Prior to joining HDFC AMC he has worked with Reliance Mutual Fund, Reliance Capital Ltd., Deutsche Securities, B&K Securities, Brics Securities, JP Morgan Securities and HSBC Securities.
    Funds Managed
    addAmar Kalkundrikar
    Education
    Mr. Kalkundrikar has done B.Com, CA, CFA, and MBA from Columbia Business School.
    Experience
    Prior to joining Nippon India Mutual Fund, he has worked with HDFC Asset Management Company Limited where he has handled multiple roles in Investment – Equity function such as Portfolio Management for PMS business, & performing Equity research in various sectors such as Consumer Staples, Consumer Discretionary, Retail, Construction Materials.
    Funds Managed
    addChirag Dagli
    Education
    Mr. Dagli has done B. COM and Chartered Accountant.
    Experience
    Prior to joining HDFC AMC, he has worked with Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
    Funds Managed

    HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend Details

    HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend is a Equity Mutual Fund Scheme launched by HDFC Mutual Fund. This scheme was made available to investors on 27 Mar 2017. Krishan Daga, Rakesh Vyas is the Current Fund Manager of HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹133 Cr and the Latest NAV as of 05 May 2020 is ₹10.00.

    The HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend is rated Moderately Low risk.

    Investment Objective

    The scheme aims to generate income through arbitrage opportunities between cash and derivative market and through investments in debt and money market instruments.

    Scheme Information Document(SID)

    Not Supported
    Min for First Investment
    Not Supported
    Min for Second Investment
    Nil
    Exit Load

    Compare Funds

    HDFC Charity Fund For Cancer Cure Arbitrage Plan Regular Dividend
    VS
    search

    About HDFC Mutual Fund

    Address
    “HDFC House”, 2nd Floor, H.T. Parekh Marg, 165-166, Backbay Reclamation, Churchgate, Mumbai 400020
    Phone
    022 6631 6333
    Launch Date
    30 Jun 2000
    Website
    NA
    HDFC Mutual Fund
    Asset Management Company
    Custodian
    NA
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Similar Funds
    Data not available